Biohaven Ltd (BHVN)
NYSE
The current BHVN market cap is 3.87B. The company's latest EPS is USD -4.0364 and P/E is -9.47.
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 0 | 0 |
Operating Income | -567.93M | -436.05M |
Net Income | -570.28M | -408.17M |
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 661.78M | 513.21M |
Total Liabilities | 123.01M | 85.24M |
Total Equity | 538.77M | 427.98M |
Market Cap | 3.87B |
Price to Earnings Ratio | -9.47 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 15.55 |
Price to Book Ratio | 9.03 |
Dividend Yield | - |
Shares Outstanding | 101.12M |
Average Volume (1 week) | 694.47k |
Average Volume (1 Month) | 992.36k |
52 Week Change | -12.85% |
52 Week High | 62.21 |
52 Week Low | 26.80 |
Spread (Intraday) | 2.66 (6.62%) |
Company Name | Biohaven Ltd |
Address |
p.o. box 173 road town, tortola |
Website | https://www.biohavenpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.